ARA-C associated pulmonary toxicity

References (4)

1. Yegin ZA, Akı S, Sucak G, Yagcı M. Cytarabine induced non cardiogenic pulmonary edema in a case of acute lymphoblastic leukemia. Int J Lab Hem 2007;29: 482-3. [CrossRef] Chagnon K, Boissel N, Raffoux E, Dombret H, Tazi A, Bergeron A. A new pattern of cytosine arabinoside induced lung toxicity. Br J Haematol 2009;147: 760-74. [CrossRef] Briasoulis E, Pavlidis N. Non cardiogenic pulmonary edema: An unusual and serious complication of anti- cancer therapy. Oncologist 2001;6:153-61. [CrossRef] Andersson BS, Cogan BM, Keating MJ, Estey EH, McCredie KB, Freireich EJ. Subacute pulmonary failure complicating therapy with high dose ARA-C in acute leukemia. Cancer 1985;56:2181-4. [CrossRef] Andersson BS, Luna MA, Yee C, Hui KK, Keating MJ, McCredie KB. Fatal pulmonary failure complicating high dose cytosine arabinoside therapy in acute leuke- mia. Cancer 1990;65:1079-84. [CrossRef] Forghieri F, Luppi M, Morselli M, Potenza L, Volzone F, Riva G, Imovilli A, Rivolti E, Torelli G. Cytarabine related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. Haematologica 2007;92:85-90. [CrossRef] Larouche G, Denault A, Prenovault J. Corticosteroids and serious cytarabine-induced pulmonary edema. Pharmacotherapy 2000;20:1396-9.
2. Salvucci M, Zanchini R, Molinari AL, Zuffa E, Poletti V, Poletti G, Zaccaria A. Lung toxicity following fludara- bine, cytosine arabinoside and mitoxantrone (FLAN) treatment for acute leukemia. Haematologica 2000;85:769-70.
3. Chiche D, Pico JL, Bernaudin JF, Chouaib S, Wollman E, Arnoux A, Denizot Y, Nitenberg G. Pulmonary edema and shock after high dose aracytine-C for lymphoma; possible role of TNF-alpha and PAF. Eur Cytokine Network 1993;4:147-51.
4. Hirshmann JV, Pipavath SNJ, Godwin JD. Hypersensitivity pneumonitis: A historical, clinical and radiologic review. Radiographics 2009;29:1921-38. [CrossRef]